Deals
Edgemont Capital Partners, a middle market healthcare investment bank with a focus on pharmaceutical services and M&A advisor to clinical research site companies, has advised Evolution Research Group (ERG), a portfolio company of DFW Capital Partners (DFW), on its sale to Linden Capital Partners (Linden).
ERG is the largest independent clinical research site services company focused on special populations and a leader in central nervous system (CNS) studies. David Blume, Managing Director and head of the Firm’s Pharmaceutical Services Group led the ERG transaction team.
Edgemont advised Thievon-Wright Consulting Group, Woodland International Research, Woodland Research Northwest and St. Louis
Actis is building an Indian Non-Banking Financial Company focused on secured lending to small and medium enterprises (SMEs) with a plan to fund the platform with up to USD220 million of equity capital over a five-year period.
India has a deep culture of small family businesses with over 30 million SMEs and the sector is experiencing growth in demand for credit. Profectus Capital will exclusively focus on lending to SME businesses operating in a dozen targeted subsectors.
Actis is backing a team led by the ex-CEO of Reliance Commercial Finance (RCF), KV Srinivasan (KV) who built one of the
GPS Insight has secured an investment from Bregal Sagemount aimed at supporting the company’s continued growth.
GPS Insight is a leading provider of SaaS-based fleet management software to customers with fleets ranging from a few vehicles to several thousand vehicles across a diverse array of industries. Bregal Sagemount is a growth-focused private equity firm that provides capital and strategic assistance to market-leading companies. Following several years of significant growth, GPS Insight plans to work in conjunction with Bregal Sagemount to further augment its solutions, expand its market reach, and drive substantial value for its customers.
“GPS Insight is excited to formally
Bowmark Capital, a mid-market private equity firm, is backing the buy-out of LOD (Lawyers On Demand), an alternative legal services provider, from Bryan Cave Leighton Paisner (BCLP).
“This is all about access to capital for our next stage of growth,” says LOD CEO Tom Hartley. “We have been exploring alternative options since the summer of 2017 following our successful merger with AdventBalance in Asia and Australia in 2016.”
Neville Eisenberg, BCLP Partner responsible for LOD, says: “BCLP is extremely proud to have been a pioneer in the alternative legal services market. Nurturing the creation of LOD over 10 years
IK Investment Partners’ (IK) IK VIII Fund is to acquire Klingel medical metal, a manufacturer of high-precision and complex metal components mainly for a range of medical technology applications, from Halder.
Klingel was established in 1986 and has become a leading independent contract manufacturer of high-precision, hard-to-machine parts made from titanium and high-grade types of stainless steel. The Company operates a vertically integrated business model with in-house capabilities spanning the entire production value chain from design to manufacture to final packaging with a strategic focus on medical technology. Klingel’s high precision components go into various orthopaedic, cardiovascular and dental implants
JAB is to acquire ready-to-eat food specialist Pret A Manger from Bridgepoint, an international private equity firm and its majority owner, and other minority shareholders.
The transaction is expected to be completed during the Summer 2018. Terms of the transaction were not disclosed.
Pret maintains a strong presence in the UK and boasts a rapidly growing international footprint with a presence in the United States, Hong Kong/China and France. Pret’s sandwiches, salads and wraps are freshly made each day in shop kitchens using quality ingredients. Pret’s offering includes an array of vegetarian or vegan sandwiches and salads, as customer
OnTruck, a haulage tech platform, has raised EUR25 million from a group of investors to fund its expansion across Europe and consolidation of its position in the UK and Spain.
The series B funding round was led by global venture capital fund Cathay Innovation, with participation from new investor GP Bullhound and existing investors Atomico, Idinvest Partners, All Iron Ventures, Total Energy Ventures, Point 9 Capital, and Samaipata Ventures.
OnTruck’s network of vetted truck drivers offers shippers guaranteed capacity and industry-leading service to ensure shipments are delivered reliably and on time. With their proprietary technology, OnTruck automates the matching
Alternative asset manager Tikehau Capital has made a EUR114 million investment in Nexteam Group, a specialist in the machining of complex and hard metal parts for the aviation and space industries.
Pending approval from the French competition authority, this minority stake, alongside Nexteam Group’s management, will support the company’s future development.
Nexteam Group is a French company specialising in precision mechanics and the machining of complex and hard metal parts for the aviation, aerospace and defence industries. With 900 employees, Nexteam Group generates annual revenues of about EUR150 million. The company has six production units in France, one unit
British soft drinks company Cawston Press has successfully raised GBP1 million in an equity fundraising round to support continued expansion at home and overseas.
The total has been reached through existing shareholders, members of the Cawston Press team from the UK, Australia and USA as well as a select number of private investors in the food and drink industry.
Steve Kearns, Managing Director of Cawston Press, says: “Our team is made up of people who want to make better quality soft drinks the norm not the niche. When we initially considered undertaking a full external fundraising round, we quickly
NVM Private Equity (NVM) has invested GBP1.0 million of growth capital into Cambridge-based medical device company Ablatus Therapeutics Limited (Ablatus) alongside existing angel investors.
Ablatus was founded in 2016 as a spin out from the NHS, under the guidance of Health Enterprise East (HEE), to develop and commercialise patented Bimodal Electric Tissue Ablation (BETA) technology. The investment from NVM will support the company through the next stage of commercialisation, including ongoing product development.
The Ablatus technology was originally developed by clinicians in the Norfolk and Norwich University Hospitals NHS Foundation Trust (the Trust), who identified a novel way to
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
